Begberon S 50mg/5mg Tablet ER

Overview Begberon S 50mg/5mg Tablet ER

Combinazione ER di Tolterodina/Solifenacina 50mg/5mg, indicated for managing overactive bladder symptoms, alleviates urinary frequency, urgency, and incontinence. Dosage and duration should strictly adhere to your physician's instructions. Administer with or without food, consistently at the same time daily. Discontinuing treatment prematurely may exacerbate symptoms; complete the prescribed course for optimal results. Commonly reported adverse effects include elevated blood pressure, upper respiratory tract infection (affecting nose and throat), urinary tract infection, and cephalalgia (headache). Report any persistent or bothersome side effects promptly. Prior to commencing treatment, disclose all current medications and any pre-existing conditions, including pregnancy or breastfeeding. Patients with hepatic or renal impairment require close monitoring and regular check-ups as directed by their doctor.

Primary Ingredients of Begberon S 50mg/5mg Tablet ER

There is no text provided to rephrase.

Uses of Begberon S 50mg/5mg Tablet ER

Symptoms associated with an overactive bladder

Major Benefits of Begberon S 50mg/5mg Tablet ER:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Begberon S 50mg/5mg Extended-Release Tablets may be consumed with or without food, though consistent timing is recommended.

Common Side effects of Begberon S 50mg/5mg Tablet ER:

• High blood pressure
• Nasopharyngitis (inflammation of the throat and nasal passages)
• Urinary tract infection
• Headache
• Dryness in mouth
• Constipation
• Increased heart rate
• Blurred vision

How to use Begberon S 50mg/5mg Tablet ER:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Begberon S 50mg/5mg Extended-Release Tablets can be consumed with or without food, although consistent timing is recommended.

How Begberon S 50mg/5mg Tablet ER works:

Begberon S 50mg/5mg Extended-Release tablets contain Mirabegron and Solifenacin, two medications that work synergistically to manage overactive bladder symptoms. Mirabegron, a beta-3 adrenergic agonist, promotes bladder muscle relaxation by stimulating specific receptors. Solifenacin, an antimuscarinic agent, achieves a similar effect through a different mechanism, also relaxing bladder muscles. This dual action reduces urinary frequency, urgency, and incontinence.

What if you forget to take Begberon S 50mg/5mg Tablet ER :

NA